← Back to patent-cliff list
Hydrocortisone/Benzocaine/Bismuth Subgallate/Benzalkonium Chloride
Tier C — Watch / tradeHydrocortisone/Benzocaine/Bismuth Subgallate/Benzalkonium Chloride
Exeltis
Originator
1997
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：SCNA, GR
Brand：Kortos
Indications (approved)：肛裂, 痔疮
Regional status
US
-
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Hydrocortisone/Benzocaine/Bismuth Subgallate/Benzalkonium Chloride?
Approved indications include: 肛裂, 痔疮.
When does the Hydrocortisone/Benzocaine/Bismuth Subgallate/Benzalkonium Chloride patent expire?
No public expiry year is available for Hydrocortisone/Benzocaine/Bismuth Subgallate/Benzalkonium Chloride yet; this page updates once verified.
How do I get a quote for Hydrocortisone/Benzocaine/Bismuth Subgallate/Benzalkonium Chloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-04